Rezultati pretraživanja
  1. prije 19 sati

    Our team is dedicated to making more effective, more broadly applicatble, and more widely available to people facing .

  2. 4. velj

    The Portuguese company is developing that prevent cells from evading the immune system by hitting sugar molecules on their surface. 🍬

  3. prije 10 sati

    genomic approaches for developing the next generation of - Nature via

  4. Lab findings have prompted a clinical trial in which scientists strive to find out if can be used to bolster the effect of in . Listen to Dr. Joshua Brody talk about the possibilities of ==>

  5. 4. velj

    (under Darpa) specializes in the creation of and , which contain that causes the cells of the recipient to produce an and can a person’s DNA. -->thread

    Prikaži ovu nit
  6. 3. velj

    Could single-cell genomic technologies hold the key to develop the next generation of ?

  7. 3. velj
  8. 1. velj

    Starting 2020 with new international projects! The Immunopathology Group is part of , a consortium developing cellular funded by

  9. 1. velj
  10. 31. sij
  11. 31. sij

    Despite progress in screening, most patients are diagnosed at advanced stages when the disease is harder to treat. Ongoing studies are investigating the use of targeted agents, , and other combination approaches to address this significant unmet need.

  12. 31. sij

    Do you want to be part of a new product launch to enhance the quality of ? We are looking for an experienced Sales and Business Development Manager in the field of or to strengthen our . See the vacancy!

  13. 31. sij

    📅 RDV aujourd’hui à la pour notre symposium sur le thème des !

  14. 31. sij

    Early Bird rego for SHPA’s Masterclass: in seminar closes next Fri 7 Feb. Attend to stay ahead of the latest developments in this rapidly-evolving field, Sat 29 Feb in Melbourne Find out more:

  15. 30. sij

    Our labs in Boston, Ann Arbor & Bonn, Germany, are working together to help solve limitations faced by current as we continue to focus on developing therapies with systemic and targeted delivery options. Learn more about our candidates:

  16. 30. sij

    Researchers have demonstrated a new engineering technique that uses and could enable a different mechanism for altering the way recognize with fewer side effects than other cancer . (Work funded by )

  17. 30. sij

    offer an exciting way to treat disease. What is their status for treating Progressive Supranuclear Palsy ()? Read the new MDS blog post.

  18. 30. sij

    What is needed to support the development of therapies? Learn the methods & platforms our scientists leverage to progress these next-gen :

  19. 29. sij

    Avacta Group POC for proprietary new class of anti-cancer therapy (Interview) - -

  20. 29. sij

    , , , ... De nombreux existent contre le . Pour mieux vous y retrouver, découvrez le dernier article de -

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.